Riesenfeld I, Alm G V
Int J Cancer. 1977 Aug 15;20(2):309-17. doi: 10.1002/ijc.2910200221.
The potential of embryonic thymus organ cultures for studies on relations of endogenous MuLV, lymphoid cells and thymic microenvironment to lymphoma development were evaluated. Four main findings are reported. First, thymuses of 14-day-old CBA and AKR embryos could be maintained in organ cultures for at least 9 weeks with sustained production of lymphocytes. Lymphopoiesis in CBA and AKR thymuses were not grossly different. Secondly, an indirect immunofluorescence (IF) technique demonstrated spontaneous appearance of MuLV-antigen-containing cells in AKR, but not in CBA thymuses. Such spontaneous MuLV expression first occurred after 16 days of organ culture, thereafter infrequently and at random in individual thymus cultures. Thirdly, incubation of AKR and CBA thymuses in lymphoma extract containing AKR-type MuLV at initiation of organ cultures induced MuLV-antigen-containing cells. These were first detected after 7-14 days in culture, somewhat earlier and initially more frequently in AKR than in CBA thymuses. In the former, induction was accompanied by a clear reduction in the number of lymphocytes per thymus. Fourthly, iododeoxyuridine (IdUrd) treatment of AKR thymuses on cultute day 0, 3 or 7 decreased the number of lymphocytes per thymus and induced appearance of MuLV-antigen containing cells, assayed 8-20 days later. The IdUrd effect was most marked on day 0, and decreased sucessively on days 3 and 7. IdUrd had a much slighter effect on CBA thymuses, causing a lower reduction in cell numbers and inducing few MuLV-antigen cells. These main results clearly demonstrate the potential usefulness of the organ culture system for studied on leukemogenesis. It may be directly applied to answer several questions raised by detailed findings in our study.
评估了胚胎胸腺器官培养在研究内源性鼠白血病病毒(MuLV)、淋巴细胞和胸腺微环境与淋巴瘤发生关系方面的潜力。报告了四项主要发现。第一,14日龄CBA和AKR胚胎的胸腺可在器官培养中维持至少9周,并持续产生淋巴细胞。CBA和AKR胸腺中的淋巴细胞生成没有明显差异。第二,间接免疫荧光(IF)技术显示,AKR胸腺中出现了含MuLV抗原的细胞,而CBA胸腺中未出现。这种自发的MuLV表达在器官培养16天后首次出现,此后在个别胸腺培养物中很少且随机出现。第三,在器官培养开始时,将AKR和CBA胸腺在含有AKR型MuLV的淋巴瘤提取物中孵育,可诱导产生含MuLV抗原的细胞。这些细胞在培养7 - 14天后首次被检测到,在AKR胸腺中比在CBA胸腺中出现得稍早且最初更频繁。在前者中,诱导伴随着每个胸腺中淋巴细胞数量的明显减少。第四,在培养第0、3或7天用碘脱氧尿苷(IdUrd)处理AKR胸腺,可减少每个胸腺中的淋巴细胞数量,并诱导出现含MuLV抗原的细胞,在8 - 20天后进行检测。IdUrd的作用在第0天最为明显,在第3天和第7天依次减弱。IdUrd对CBA胸腺的作用要小得多,导致细胞数量减少较少,且诱导产生的含MuLV抗原细胞很少。这些主要结果清楚地证明了器官培养系统在白血病发生研究中的潜在用途。它可直接用于回答我们研究中的详细发现所提出的几个问题。